‎Singapore: ReSearch Pharmaceutical Services (RPS) and Japan-based Asklep have formed a joint venture comp...
Tokyo:Â Nipro Corporation, headquartered in Osaka, Japan, has signed a definitive agreement to acquire US headquartere...
Singapore: The US arm of Japan's Eisai has entered into a worldwide collaboration with Purdue Pharma to develop and comm...
Tokyo-headquartered Dentsu Inc announced that the company's corporate venture capital arm Dentsu Ventures Global Fund ha...
Japanese pharmaceutical major Eisai Co. Ltd. has submitted applications to regulatory authorities in Japan, United State...
Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio ...
Singapore: Eisai published the results of its 'adjunctive perampanel for refractory partial-onset seizures: randomized p...
Singapore: US FDA approved Eisai's Aciphex Sprinkle delayed-release capsules 5mg and 10mg for the treatment of gastroeso...
Singapore: BioSpectrum feels the pulse of Asia's top destinations and major players in medical tourism. Medical ...
Singapore: GlaxoSmithKline (GSK) has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has grant...
Japan's Taiho Pharmaceutical Co. Ltd. and France's Servier have entered into an exclusive license agreement on June 12, ...
Japanese pharmaceutical firms, Daiichi Sankyo Company Limited and UCB Japan Co. Ltd have announced that UCB Japan has ap...
Tokyo: PeptiDream Inc., a Tokyo-based biopharmaceutical company, has signed a multi-target discovery and optimization co...
Singapore: Japan's Denki Kagaku Kogyo Kabushiki Kaisha (Denka Group) recently inked a pact to acquire Germany's Icon Gen...
Osaka-headquartered Ono Pharmaceutical Co Ltd and Bristol-Myers Squibb K K have launched Orencia Subcutaneous Injection ...
Singapore: WuXi PharmaTech's small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmace...
Singapore: AG Mednet signed a master services agreement with Biovisiq, a Japanese imaging core laboratory (ICL), to redu...
Singulex Inc., California-based developer and provider of Single Molecule Counting technology for clinical diagnostics a...
Singapore: With a capital of $30 million, Tokyo based Chugai Pharmaceutical has announced to establish a wholly owned dr...
Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-...
Singapore: Researchers from the RIKEN Research Centre for Allergy and Immunology in Japan have succeeded, for the first ...
The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the ...
Singapore: Life Technologies has signed a non-exclusive agreement with iPS Academia Japan for its induced pluripotent st...
A team of chemists and biologists at the Institute of Transformative Bio-Molecules (ITbM), Nagoya University, Japan, hav...
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Jap...
